Please enable JS

EFESO Consulting has been appointed as a trusted partner by PAI Partners to perform two due diligence as part of the acquisitions of the industrial leaders SGD Pharma and Pasubio

NEWS RELEASE

Paris, 16/07/2021 - EFESO Consulting has been appointed as a trusted partner by PAI Partners to perform two due diligence as part of the acquisitions of the industrial leaders SGD Pharma and Pasubio.

EFESO Consulting has recently advised PAI Partners, a leading European private equity firm, with a deep assessment and analysis of the Operations of two of their potential acquisitions:

  • SGD Pharma, a world leading company in the pharmaceutical glass packaging industry. Headquartered in France, the group generates a 347.5 M€ turnover and employs 3,200 people worldwide. It produces over 8 million vials and bottles per day at its five manufacturing plants in Europe and Asia.
  • Pasubio, a leading European leather manufacturer, which produces high quality leather products for car interiors serving the premium and luxury automotive segments. The group is headquartered in Italy employs around 1,000 people and operates six facilities

The EFESO Consulting team carried out a CAPEX plan assessment and recommendations, cost line improvement validation, plants’ production capacity and industrial footprint, and a digital maturity assessment.

The two deals resulted in an exclusive negotiation. The transactions remain subject to works council consultation, approval from China’s Finance ministry (for SGD Pharma), and customary antitrust approvals and are expected to be validated before the end of 2021.

The EFESO Consulting team involved in these due diligence: Virginie Fiacre, Matthieu Champavier, François Noël, Stefano Erba, Lorenzo Zennaro, Ettore Baldissarra, Alberto Porcelli and Andrea Mantegazza.